Sarcoma
📧 Sign up to get email alerts when something new happens for Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas [Phase 2]
Phase 2 study ARTEMIS-002 (HS-20093) is evaluating HS-20093 in patients with relapsed or refractory osteosarcoma and other sarcomas; the tri…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors [Phase 1, Phase 2]
This update reports the termination of a Phase 1/2 trial of AMG 655 in combination with AMG 479 for advanced, refractory solid tumors, with …
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Pazopanib Maintenance Phase II [Phase 2]
A Phase 2 maintenance trial of pazopanib in patients with sarcoma was terminated, and results have been posted.
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Enhanced Recovery After Surgery in Extremity Sarcoma [NA]
This clinical trial update reports on an Enhanced Recovery After Surgery program for patients with extremity sarcoma, and the study is curre…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma [Phase 2]
A Phase 2 trial evaluating trabectedin in combination with olaparib for advanced unresectable or metastatic sarcoma has completed, with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers [NA]
This clinical trial update indicates the study evaluating cardiac rehabilitation for patients receiving radiation therapy for thoracic cance…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma [Phase 2]
A Phase 2 clinical trial evaluating metronomic gemcitabine, doxorubicin, docetaxel, and nivolumab for advanced sarcoma is currently recruiti…
-
CLINICAL_TRIALS withdrawal · 2024-07-05Clinical Trial Update: Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures
A clinical trial evaluating autologous natural killer cell therapy in primary cancer cell cultures for sarcoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of Stimotimagene Copolymerplasmid in multiple cancer types; the study ha…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PRT3645 conducted by Prelude Therapeutics in patients with several advanced solid tumors has completed, including breast …
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas
The clinical trial update reports completion of a study evaluating treatments for leukemia, brain tumors, and sarcomas in children and adole…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors [Phase 1]
Phase I trial update of T cells engineered to express an anti-GD2 chimeric antigen receptor in children and young adults with GD2-positive s…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with stereotactic ablative radiotherapy for metastatic colorectal cancer, non-…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating simultaneous hyperpolarized [1-13C]pyruvate and 18F-FDG PET/MRS in cancer patients is currently enrollin…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma [Phase 1, Phase 2]
Phase I/II clinical trial of LTC004 for unresectable or metastatic sarcoma; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Pilot RCT of the PRISM Intervention for AYAs With Cancer [Phase 2]
pilot randomized Phase 2 trial evaluating the PRISM intervention for adolescents and young adults with cancer, completed.
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors [Phase 2, Phase 3]
A Neoadjuvant combination therapy trial using doxorubicin, cisplatin, and methotrexate in young adults with primary bone tumors has reported…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types [Phase 2]
Phase 2 trial update indicating access to pembrolizumab for selected rare cancer types has been secured.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma [Phase 1]
Phase I trial evaluating the effects of food and formulation on pharmacokinetics of KPT-330 (selinexor) in patients with sarcoma.
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Chidamide Combined With Toripalimab in Sarcoma [Phase 2]
Phase 2 clinical trial evaluating chidamide in combination with toripalimab for sarcoma is underway, with an unknown current status.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers [NA]
This completed clinical trial evaluated palliative lattice stereotactic body radiotherapy (SBRT) for patients with sarcoma and other thoraci…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating YH001 plus Envafolimab with or without doxorubicin in advanced or metastatic sarcoma (including soft t…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype [Phase 3]
Phase 3 trial evaluating nivolumab plus ipilimumab for sarcoma of rare subtypes; results not yet available.